Andrew Whale
Director - Nonclinical Safety Immunocore Ltd
Seminars
Thursday 3rd December 2026
Insight Exchange – Can We Ever Reliably Predict Safety & Efficacy Before the Clinic?
11:50 am
- Which endpoints remain hardest to predict with current models?
- How should teams balance efficacy and safety when selecting models?
- What breakthroughs are needed to improve prediction of clinical outcomes?
- Audience Q&As
Thursday 3rd December 2026
Evidence – Predicting Safety & Clinical Outcomes Using Preclinical Tumour & Normal Tissue Models with T-Cell Engagers
11:30 am
- In vitro approaches to assess safety and efficacy of T cell engagers
- Understanding the opportunities and limitations of current in vitro and in vivo systems in predicting unwanted side effects
- Exploring emerging approaches to improve safety assessment in early drug development
